Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis

article-08-08-2020

Please CLICK HERE to read the article, “Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis

/ Uncategorized
  • Next Post
  • Previous Post
SIGN UP NOW

Click here to participate in a study

NRI CLINICS ARE CURRENTLY OPEN!
X